Modifi Biosciences, Inc. — Form D
Modifi Biosciences, Inc. of NEW HAVEN, CT, a company, filed a Form D exempt-offering notice with the SEC on 2024-08-29. The offering totals $1.0M, of which $996K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-08-29
- Form: D
- Accession: 0001922279-24-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.0M
- Amount sold: $996K
- Remaining: $4K
- Investors: 39
- Date of first sale: 2024-08-19
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-522797
Issuer
- Name: Modifi Biosciences, Inc.
- CIK: 0001922279
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 55 CHURCH STREET, NEW HAVEN, CT, 06510
- Phone: 2034352255
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Ranjit L Bindra | Director | New Haven, CT |
| Lucas L de Breed | Director | Framingham, MA |
| Kat L Kayser-Bricker | Director | Branford, CT |
| Kevin L Rakin | Director | Westport, CT |
| Kevin L Rakin | Executive Officer | Westport, CT |
| Seth L Herzon | Director | Essex, CT |
Other filings by this issuer (2)
More